Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State

Por Baxevanis, Constantin N., Perez, Sonia A.
Publicado no Vaccines (Basel) (2015)

Endogenous immunity at the forefront of tumor dormancy

Por Baxevanis, Constantin N, Perez, Sonia A
Publicado no Future Sci OA (2015)

Immunologic biomarkers in prostate cancer: The AE37 paradigm

Por Baxevanis, Constantin N, Papamichail, Michael, Perez, Sonia A
Publicado no Hum Vaccin Immunother (2014)

New insights into the role of NK cells in cancer immunotherapy

Por Salagianni, Maria, Baxevanis, Constantin N., Papamichail, Michael, Perez, Sonia A.
Publicado em 2012

MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells

Por Anastasopoulou, Eleftheria A., Voutsas, Ioannis F., Papamichail, Michael, Baxevanis, Constantin N., Perez, Sonia A.
Publicado no Oncoimmunology (2016)

Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide

Por Voutsas, Ioannis F., Anastasopoulou, Eleftheria A., Tzonis, Panagiotis, Papamichail, Michael, Perez, Sonia A., Baxevanis, Constantin N.
Publicado no J Immunother Cancer (2016)

Immune profiling of breast cancer patients: relationship between tumour antigen T cell responses with suppressor and effector leukocyte populations

Por Janssen, Nicole, Pawelec, Graham, Speigl, Lisa, Fortis, Sotirios P, Haritos, Christoforos, Perez, Sonia A, Baxevanis, Constantin N, Bailur, Jithendra Kini, Shipp, Christopher
Publicado no J Immunother Cancer (2015)

Linking tumor with systemic environment in the search for novel biomarkers in breast cancer

Por Fortis, Sotirios P, Mahaira, Louisa G, Sofopoulos, Michael, Sotiriadou, Nectaria, Haritos, Christoforos, Voutsas, John F, Anastasopoulos, Nikolaos, Arnogiannaki, Niki, Shipp, Christopher, Pawelec, Graham, Perez, Sonia A, Baxevanis, Constantin
Publicado no J Immunother Cancer (2015)

DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine

Por Anastasopoulou, Eleftheria A, Tzonis, Panagiotis, Fortis, Sotirios P, Mahaira, Louisa, Vaxevanis, Christoforos, Ardavanis, Alexandros, Mittendorf, Elizabeth A, Peoples, George E, Baxevanis, Constantin N, Papamichail, Michael, Perez, Sonia A
Publicado no J Immunother Cancer (2015)

Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine

Por Greene, Julia, Schneble, Erika, Martin, Jonathan, Flores, Maddie, Trappey, Alfred, Berry, John, Vreeland, Timothy, Hale, Diane, Clifton, Guy, Perez, Sonia A, Papamichail, Michael, Peoples, George, Mittendorf, Elizabeth, Ponniah, Sathibalan
Publicado no J Immunother Cancer (2014)

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence

Por Mittendorf, Elizabeth A., Ardavanis, Alexandros, Litton, Jennifer K., Shumway, Nathan M., Hale, Diane F., Murray, James L., Perez, Sonia A., Ponniah, Sathibalan, Baxevanis, Constantin N., Papamichail, Michael, Peoples, George E.
Publicado no Oncotarget (2016)

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

Por Fortis, Sotirios P., Sofopoulos, Michael, Sotiriadou, Nectaria N., Haritos, Christoforos, Vaxevanis, Christoforos K., Anastasopoulou, Eleftheria A., Janssen, Nicole, Arnogiannaki, Niki, Ardavanis, Alexandros, Pawelec, Graham, Perez, Sonia A., Baxevanis, Constantin N.
Publicado no J Immunother Cancer (2017)

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

Por Fortis, Sotirios P., Sofopoulos, Michael, Sotiriadou, Nectaria N., Haritos, Christoforos, Vaxevanis, Christoforos K., Anastasopoulou, Eleftheria A., Janssen, Nicole, Arnogiannaki, Niki, Ardavanis, Alexandros, Pawelec, Graham, Perez, Sonia A., Baxevanis, Constantin N.
Publicado no J Immunother Cancer (2017)